The M&A question is never far away for medtech companies that successfully restructure, set ambitious but achievable goals and whose portfolios and markets are relatively easily defined. Thus, device industry commentators have recently been prone to couple upper/lower extremities and biologics manufacturer Wright Medical Group NV, newly augmented by its 2015 Tornier NVacquisition, with suitors as the combined group continues to show robust financial performances.
Add to the mix the contention in some quarters that president and CEO Bob Palmisano has had an M&A agenda...